A growing cannabis market makes for a perfect time to invest in marijuana companies

If you’re looking for new and profitable stocks to invest in, the cannabis industry offers a perfect opportunity! Imagine if you bought stocks in Amazon or Google during the early days of the internet. Investing in some cannabis companies is likely to be similar to that! The main reason why these companies are so successful nowadays is that certain regions of the world have already legalized cannabis, and there’s likely to be more encouraging marijuana news in the future as more areas legalize it.

In fact, 66% of Americans support the federal legalization of cannabis. The recreational cannabis market is expected to have a compound annual growth rate of 36.4% between now and 2025, and there has been a 140% increase in first-time cannabis use. However, it’s not just recreational cannabis that companies are profiting from.

In fact, doctors are becoming increasingly aware of the medicinal benefits of cannabis, and research has found that it has beneficial properties for a wide range of conditions. Many patients have found that treatment with cannabis is truly life-changing for them, and 76% of doctors now approve of medical cannabis. The expected compound annual growth rate between the period of 2018 and 2022 has been estimated at more than 21%. This means that many companies today are doing extremely well by offering cannabis products for medicinal use. Here are a few examples of conditions that medicinal cannabis can be used to treat:

– Chronic pain: Individuals who suffer from chronic pain often find that cannabis is a safe and highly effective treatment. Cannabis does not have the potentially hazardous side effects that are associated with conventional pain medications, and it is not known to cause physical addiction. Chronic pain sufferers make up an extremely large portion of the market for medicinal cannabis.

– Epilepsy: Cannabis has even been found to be effective in some epilepsy cases where traditional medications are not. The anti-epileptic properties of the plant are largely due to a compound in cannabis called CBD, and some companies have made money by offering strains of cannabis that are specially bred to be beneficial for epilepsy sufferers.

– Side effects of chemotherapy: Individuals who are receiving chemotherapy often find that they experience a reduced amount of nausea and other side effects after taking cannabis medicinally. Also, it often produces fewer side effects than conventional medications that are used to manage chemotherapy side effects.

– Cannabis may have anti-cancer properties: While cannabis alone is not used to treat cancer, some researchers believe that combining it with conventional treatments could aid in recovery.

– Anxiety and depression: In some cases, cannabis can be just as effective for depression and anxiety as conventional medications, and it often works immediately, while some conventional medications take a period of weeks to begin working. Furthermore, it doesn’t cause the side effects that are associated with conventional anti-depressants and anti-anxiety medications. Anxiety and depression sufferers make up a significant portion of the market for medicinal cannabis.

– Serious mental health issues: Some studies indicate that cannabis could be beneficial for people who suffer from bipolar disorder, and it may help to stabilize mood in some cases. Furthermore, many researchers believe that CBD has anti-psychotic properties, and this could be beneficial for many types of severe mental illness.

– Asthma and other respiratory problems: While smoking cannabis is not beneficial for respiratory conditions, the plant has effects that dilate the lungs, and this means that cannabis in edible form can help those with respiratory problems. Asthma and other conditions of the respiratory system are quite common.

– Alzheimer’s disease: Some research indicates that cannabis is capable of slowing down the progression of Alzheimer’s disease, and if this is confirmed, it could expand the cannabis market to include numerous elderly individuals and would be one of the most groundbreaking marijuana news stories ever.

– Glaucoma: Glaucoma is a common and serious condition of the eye, and research has shown that cannabis is often extremely effective for people who suffer from it. If research allows doctors to derive more effective glaucoma medications from cannabis, it could allow the market to grow significantly.

– Inflammatory diseases: Many diseases, such as arthritis, are caused by inflammation in the body. There are compounds in the cannabis plant that have very well-documented anti-inflammatory effects, and this can allow cannabis to treat the cause of chronic pain in some cases instead of just masking the symptoms.

How big is the market for cannabis right now?

Currently, around 100 million people in North America live in an area where recreational cannabis is legal, and a large majority of people in the US (and all of Canada) live in a region where medicinal cannabis has been legalized. It’s estimated that 40 million people in North America are current cannabis users.

How big could the market become in the future?

The sky is truly the limit when it comes to how large the cannabis market could become. As more people become aware of its safety and medical uses, more people may begin to use it. Eventually, cannabis could be legalized at a federal level, and this could dramatically increase the size of the market.

What are some examples of cannabis companies that you should consider investing in?

– Tilray: Tilray produces both cannabis products and conventional pharmaceuticals, and the company is based out of Canada. There was a period of rapid growth for a few months after the company began offering publicly traded stocks.

While some have said that Tilray enjoyed a brief bubble of success that has passed, other experts believe that the company could grow rapidly yet again in the future.

– Canopy Growth: Canopy Growth is also a Canadian company, and they have shown a pattern of steady growth. In addition, Canopy Growth is backed by a company that makes alcohol-containing beverages called Constellation Brands, and this helps to improve the company’s stability.

– Cronos Group: Cronos Group operates worldwide, and they produce and distribute cannabis legally. One bit of stunning marijuana news is that this company’s stock has jumped 45% in a one year period!

– Auxly Cannabis: While Auxly is not showing the dramatic growth that many other cannabis companies are, the company certainly does have a lot of potential. One thing that sets this company apart from other major companies in the industry is that it has an exceptionally low cash to debt ratio.

– Aurora Cannabis: Aurora Cannabis offers a wide range of cannabis products for Canadian customers. While the company has had some difficulties, a recent buyout is expected to allow Aurora to begin to supply cannabis to the medical marijuana industry of Latin America, and this could allow for dramatic growth.

– Origin House: Origin House plays an extremely strong role in California’s cannabis market, and California currently has a larger legal cannabis market than anywhere else in the world. This shows just how powerful this brand is.

– Marimed: While most cannabis stocks are not particularly stable, this one doesn’t show the huge ups and downs that are common in the cannabis industry. If you’re looking for a company that shows steady, long-term growth, this may be the best one in the entire industry to pick. Furthermore, Marimed has made dramatic gains of 80% in a one year period.

Some companies are specializing in CBD

The market for CBD-only products is even larger than medical and recreational marijuana due to the fact that CBD is legal in all 50 states. Another reason why the market for CBD is exceptionally large is that the fact that it’s non-psychoactive, which means that it can be used in settings where cannabis containing THC cannot, such as while driving or on the job. However, the legalization of CBD on a federal level is a recent development and has the potential to allow companies in this sector of the cannabis industry to grow dramatically. In fact, CBD sales are expected to be over a billion dollars in 2020 and more than 1.8 billion dollars in 2022. The sales may even reach 23 billion dollars in 2023!


10 Top Pot Stocks to Buy





The post A growing cannabis market makes for a perfect time to invest in marijuana companies appeared first on Learn Sativa Institute of Cannabis Education & Training .

Site Link